Crawford Investment Counsel Inc Gilead Sciences, Inc. Transaction History
Crawford Investment Counsel Inc
- $5.7 Billion
- Q3 2024
A detailed history of Crawford Investment Counsel Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Crawford Investment Counsel Inc holds 338,993 shares of GILD stock, worth $33.8 Million. This represents 0.5% of its overall portfolio holdings.
Number of Shares
338,993
Previous 343,754
1.39%
Holding current value
$33.8 Million
Previous $23.6 Million
20.48%
% of portfolio
0.5%
Previous 0.45%
Shares
10 transactions
Others Institutions Holding GILD
# of Institutions
1,979Shares Held
996MCall Options Held
10.5MPut Options Held
9.85M-
Black Rock Inc. New York, NY121MShares$12 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$11.5 Billion0.18% of portfolio
-
Capital World Investors Los Angeles, CA76.5MShares$7.63 Billion1.03% of portfolio
-
Capital Research Global Investors Los Angeles, CA61.8MShares$6.16 Billion1.12% of portfolio
-
State Street Corp Boston, MA60.2MShares$6 Billion0.21% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $125B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...